News Resources | Texas Oncology After a stage IV colon cancer diagnosis, Aline found hope through Texas Oncology and a clinical trial that helped her regain strength and fight back After an EBV-linked cancer diagnosis, Warb turned adversity into action, improving air quality for fellow patients while fighting his own battle
Treatment of Stage IV- Metastatic or Recurrent Colon Cancer Colon cancer is classified as stage IV or metastatic when the cancer has spread to distant locations in the body and cannot be primarily treated with surgery; this may include the liver, lungs, bones, distant lymph nodes or other sites Patients diagnosed with stage IV colon cancer have an increasing number of treatment options as a result of genomic testing and the development of precision
Survival Rates for Colorectal Cancer Survival rates of colorectal cancer are based on previous outcomes of people who've had the disease Find the survival rates for colon and rectal cancer here
Minimal Residual Disease Testing for the Early Detection of . . . This clinical trial compares minimal residual disease (MRD) testing with the Haystack blood test (assay) to the Signatera® assay for the early detection of the cancer returning (cancer recurrence) in patients with stage II-IV colorectal cancer (CRC) that can be removed by surgery (resectable) MRD testing looks for evidence of remaining tumor following treatment that is only apparent using
Fenbendazole, Ivermectin and Mebendazole for Colorectal . . . This article deals with the basis and practical approach to using Fenbendazole and Ivermectin for colorectal cancer Can Fenbendazole or and Mebendazole and Ivermectin play a key role in treating Stage 4 Colorectal Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might: